8 unknown, 5 recruiting, 3 not yet recruiting, 2 completed. 12 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Unknown 6, Not yet recruiting 2, Completed 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1 |
Follow Meril Life Sciences Pvt. Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Myval THV Series With Guideline-Directed Medical Therapy in Participants With Moderate Aortic Stenosis Transcatheter aortic valve Implantation - Moderate Aortic Stenosis | Not applicable | Not yet recruiting | Meril Life Sciences Pvt. Ltd. | 778 | 2026-05-17 | 2026-05-06 |
| Safety and Performance of Dafodil Heart Valves in Real-World Aortic and Mitral Valve Replacement Dafodil™ / Dafodil Neo™ Pericardial Bioprosthetic Heart Valve - Aortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction, Valvular Heart Disease Requiring Surgical Aortic or Mitral Valve Replacement | Not yet recruiting | Meril Life Sciences Pvt. Ltd. | 500 | 2026-04-01 | 2026-02-03 | |
| OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure Percutaneous coronary intervention with protocolized implantation of a second generation thin-strut bioresorbable scaffold guided by intracoronary imaging - Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI) | Recruiting | Albert Schweitzer Ziekenhuis, Netherlands | 117 | 2025-11-04 | 2026-05-18 | |
| Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI) Transcatheter aortic valve implantation - Severe Aortic Stenosis | Not applicable | Enrolling by invitation | Rede Optimus Hospitalar SA | 620 | 2025-08-08 | 2026-08-25 |
| Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry Myval THV series - Aortic Valve Stenosis, TAVI(Transcatheter Aortic Valve Implantation) | Recruiting | Portuguese Association of Interventional Cardiology | 150 | 2025-05-13 | 2026-01-16 | |
| MYLEAD Spanish Prospective Registry TAVR - Severe Aortic Valve Stenosis | Recruiting | Hospital Clínico Universitario de Valladolid | 500 | 2024-10-23 | 2025-04-08 | |
| Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS) - Coronary Artery Disease | Not applicable | Withdrawn | Meril Life Sciences Pvt. Ltd. | 2022-10-15 | 2026-04-17 | |
| Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter - Coronary Artery Disease | Not applicable | Unknown | University National Heart Hospital | 106 | 2022-10-01 | 2024-01-09 |
| Freedom® Total Knee System for Treatment of Osteoarthritis, Rheumatoid Arthritis or Post-traumatic Arthritis Freedom® Total Knee System - Knee Osteoarthritis, Rheumatoid Arthritis | Not applicable | Not yet recruiting | Meril Life Sciences Pvt. Ltd. | 450 | 2021-01-01 | 2020-10-05 |
| LANDMARK Trial: a Randomised Controlled Trial of Myval THV Myval THV Series, Contemporary Valves (Sapien THV Series and Evolut THV Series) - Aortic Valve Stenosis | Not applicable | Recruiting | Meril Life Sciences Pvt. Ltd. | 988 | 2020-11-04 | 2026-08-17 |
| Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis. Myval Transcatheter Heart Valve Series - Aortic Valve Stenosis | Recruiting | Meril Life Sciences Pvt. Ltd. | 200 | 2020-08-07 | 2024-03-04 | |
| Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. MeRes100 Sirolimus-Eluting BioResorbable Vascular Scaffold System, Xience EES Everolimus Eluting Coronary Stent System - Coronary Artery Disease | Not applicable | Unknown | Meril Life Sciences Pvt. Ltd. | 484 | 2020-01-01 | 2019-08-14 |
| Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. BioMime™ Morph - Sirolimus Eluting Coronary Stent System, Xience family Everolimus Coronary Stent Systems - Coronary Artery Disease | Not applicable | Unknown | Meril Life Sciences Pvt. Ltd. | 200 | 2019-09-15 | 2019-08-14 |
| THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer Three-row circular stapler, Two-row circular stapler - Anastomotic Leak, Anastomotic Haemorrhage | Not applicable | Unknown | Russian Society of Colorectal Surgeons | 154 | 2019-04-10 | 2019-10-08 |
| A Prospective, Single-arm, Multi-centre, Observational, Real World Registry Sirolimus Eluting Coronary Stent System - Angina Pectoris | Unknown | Meril Life Sciences Pvt. Ltd. | 400 | 2017-02-02 | 2020-02-21 | |
| Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent BioMimeTM Stent, Ultimaster® Stent - Ischemic Heart Disease | Unknown | Hyeon-Cheol Gwon | 2000 | 2016-04-01 | 2018-02-09 | |
| Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System - Coronary Artery Disease | Not applicable | Unknown | Meril Life Sciences Pvt. Ltd. | 64 | 2016-02-02 | 2018-08-17 |
| BioMime Vs. Xience Randomised Control Clinical Study Sirolimus Eluting Coronary Stent, Everolimus-eluting Coronary stent - Coronary Artery Disease | Not applicable | Unknown | Meril Life Sciences Pvt. Ltd. | 256 | 2014-11-05 | 2018-08-17 |
| An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study. Coronary Artery Disease | Completed | Meril Life Sciences Pvt. Ltd. | 250 | 2009-08-27 | 2018-04-11 | |
| Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions Sirolimus Eluting Coronary Stent System (Biomime) - Coronary Artery Disease | Not applicable | Completed | Meril Life Sciences Pvt. Ltd. | 30 | 2009-04-01 | 2018-04-05 |
Coronary Artery Disease (8) · Aortic Valve Stenosis (5) · Anastomotic Leak (1) · Angina Pectoris (1) · Aortic Valve Disease (1) · Arthritis, Rheumatoid (1) · Dysequilibrium syndrome (1) · Myocardial Ischemia (1) · Osteoarthritis, Knee (1) · Rectal Neoplasms (1)
Transcatheter Aortic Valve Replacement (2) · Percutaneous Coronary Intervention (1)
Netherlands (6) · Spain (4) · Brazil (3) · Italy (3) · Poland (3) · Czechia (2) · Estonia (2) · France (2) · Germany (2) · Hungary (2) · India (2) · Malaysia (2) · North Macedonia (2) · Portugal (2) · Slovenia (2)
Andreas Baumbach, MD,FESC,FRCP (1) · Ashok Thakkar, Ph.D. (1) · Dr. Ajit Mullasari, DNB, DM, MD, MBBS (1) · Dr. Alexandre Abizaid (1) · Dr. Alexandre Abizaid, Ph.D, MD (1) · Dr. Andrejs Erglis, MD (1) · Dr. Andrzej Ochala (1) · Dr. Ashok Seth, FRCP, FACC,FMRCP, MBBS (1) · Dr. C. N. Manjunath, DM, MD, MBBS (1) · Dr. Elvin Kedhi, Ph.D, MBBS (1) · Dr. Emanuele Barbato, Professor (1) · Dr. Ertugrul Okuyan (1) · Dr. Expedito Ribeiro, MD (1) · Dr. Farzin F Ordoubadi, B.Sc, MB BCHIR, MRCP, MD, FRCP (1) · Dr. Felix Mahfoud, Professor (1)
PMID 31192938, PMID 33160946, PMID 33269506, PMID 33833944, PMID 38795719, PMID 39589296, PMID 40875489, PMID 41079007, PMID 41384893, PMID 42572962, PMID 42701683